PubMed Health⌕ Search

PubMed · 11456863

Dodecahydroxy-closo-dodecaborate(2-).

Abstract

The cesium salt of the icosahedral borane anion dodecahydroxy-closo-dodecaborate(2-), Cs(2)[closo-B(12)(OH)(12)], Cs(2)1, was prepared by heating cesium dodecahydro-closo-dodecaborate(2-), Cs(2)[closo-B(12)H(12)], Cs(2)2, with 30% hydrogen peroxide. The other alkali metal salts A(2)1 (A = Li, Na, K, Rb) precipitated upon addition of ACl to warm aqueous solutions of Cs(2)1. The ammonium salt, [NH(4)](2)1, and the (mu-nitrido)bis(triphenylphosphonium) salt, [PPN](2)1, were obtained similarly. The [H(3)O](2)1 salt precipitated upon acidification of aqueous solutions of Cs(2)1 with hydrochloric acid. The solubility of these salts in water was determined by measuring the boron content of saturated aqueous solutions of A(2)1 (A = Li, Na, K, Rb, Cs), [H(3)O](2)1, and [NH(4)](2)1 using ICP-AES. Although these salts are derived from a dianion with twelve pendant hydroxyl groups, the alkali metal salts surprisingly displayed low water solubilities. Water solubility decreases with a decrease in the radius of A(+), except for the lithium salt, which is slightly more soluble than the potassium salt. The [H(3)O](2)1 and the [NH(4)](2)1 salts provide rare examples of water-insoluble hydronium and ammonium salts. The low water solubility of the A(2)1 salts is attributed to the dianion's pendant hydroxyl groups, which appear to function as cross-linking ligands. Four alkali metal salts, A(2)1 (A = Na, K, Rb, Cs), were characterized in the solid state by single-crystal X-ray crystallography. These data revealed intricate networks in which several anions are complexed through their hydroxyl groups to each alkali metal cation. In addition, the anions are engaged in hydrogen bonding with each other and, if present, with water of hydration. This cross-linking results in the precipitation of aggregated salts. Cation coordination numbers decrease with cation radius. Thus, cesium and rubidium are ten-coordinate, whereas potassium is seven-coordinate and sodium is six-coordinate. The geometry of anion 1(2)(-) is independent of cation identity; the B-B and B-O bond lengths of the various A(2)1 salts (A = Na, K, Rb, Cs) are identical.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T Peymann, C B Knobler, S I Khan, M F Hawthorne. 2001-03-14. Dodecahydroxy-closo-dodecaborate(2-).. https://doi.org/10.1021/ja0014887

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗